Resolution: standard / high
Figure 2.
Total progression free survival (PFS) of patients with ABC in the 2nd+ line of treatment, who received a modified biweekly regimen of BEV and PAC.
Ardavanis et al. BMC Cancer 2009 9:338 doi:10.1186/1471-2407-9-338
Download authors' original image
